Latest news
Reflecting on decades of rich history that led to our modern MG treatments - Myasthenia Gravis NewsMyasthenia Gravis News · Wed, 05 Aug 2026 20:47:20 GMTXencor Reaches $105 Million Ultomiris Royalty Settlement With Alexion; U.S. Royalties End - TradingViewTradingView · Wed, 29 Jul 2026 20:13:01 GMTXencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter - Business WireBusiness Wire · Wed, 29 Jul 2026 20:01:00 GMTAstraZeneca reports Phase III results for Ultomiris and Sone-Ve - Clinical Trials ArenaClinical Trials Arena · Tue, 28 Jul 2026 10:33:48 GMTUltomiris miss in rare thrombotic disorder provides another blot on AstraZeneca's copybook - FirstWord PHARMAFirstWord PHARMA · Mon, 27 Jul 2026 15:34:56 GMTUltomiris fails to beat placebo in adult HSCT-TMA trial, narrowing approval path to children - AllSciAllSci · Mon, 27 Jul 2026 11:28:04 GMTAstraZeneca’s rare disease drug misses main goal in late-stage trial - 101 WIXX101 WIXX · Mon, 27 Jul 2026 09:23:30 GMTUltomiris fail mars AZ's strong Q2 results - pharmaphorumpharmaphorum · Mon, 27 Jul 2026 09:14:55 GMT